Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: A universal NET liquid biopsy biomarker is required for optimal management of NET disease.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author: Modlin I
Authors: Modlin I, Kidd M, Drozdov I, Alexandra K,
Keywords: NETest, biomarker, liquid biopsy, diagnostic,
#2977 Predicting Survival in Patients with a Neuroendocrine Tumor of the Small Intestine (SI-NET)
Introduction: SI-NET comprise the largest group of neuroendocrine tumors. Because of their heterogeneity, predicting survival has proven challenging. A nomogram (NG) to assess SI-NET disease specific survival (DSS) has been developed in 2010 by Modlin, et al. based on analysis of retrospective data from the Surveillance, Epidemiology and End Results (SEER) database.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Levy S, van Veenendaal L, Korse C, Verbeek W, Vriens M,
Introduction: Neuroendocrine differentiation and an aggressive phenotype is an important feature of castration-resistant prostate cancer (CRPC). Current biomarkers are unable to detect these advanced, treatment refractory variants.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Modlin I
Authors: Modlin I, Kidd M, Rahbar K, Malczewska A, Rajwa P,
Keywords: Biomarker, NETest, PSA, prostate cancer, neuroendocrine phenotype, castration-resistance, neuroendocrine,
Introduction: There is currently no effective blood biomarker for lung neuroendocrine neoplasia diagnosis and management.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Modlin I
Authors: Modlin I, Kidd M, Lewczuk-Myślińska A, Chung K, Ćwikła J,
Keywords: bronchopulmonary, lung, biomarker, PCR, diagnostics, progression,
#1878 Measurement in Blood of a Circulating NET mRNA Gene to Predict Surgical Efficacy
Introduction: Surgery is the only curative treatment for GEP-NETs, but identifying post-surgery residual disease is difficult and often delayed.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Kidd M
Authors: Modlin I, Frilling A, Salem R, Cichocki A, Ćwikła J,